Global Pharmatech

Maiva Pharma (formerly Global Pharmatech) is a specialized contract development and manufacturing organization (CDMO) focused on sterile injectables and ophthalmic products. Headquartered in Bengaluru, India, the company operates a USFDA and EU-GMP approved facility in Hosur that produces liquid vials, ampoules, and lyophilized products for global markets including the US, Canada, and Europe. In 2024, Maiva raised $120 million from Morgan Stanley Private Equity Asia and India Life Sciences Fund to expand its manufacturing footprint and add capabilities for pre-filled syringes and oncology injectables. The company serves over 40 global customers and maintains a portfolio of more than 75 products, positioning itself as a key player in the high-growth sterile manufacturing sector.